The chronic treatment of amlodipine in regressing hypertrophy.
Patel
V B
VB
Department of Clinical Biochemistry, King's College School of Medicine & Dentistry, London, England.
Richardson
P J
PJ
Paice
A G
AG
Preedy
V R
VR
D017311:Amlodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D004247:DNA / Q000378:metabolism; D006352:Heart Ventricles / Q000378:metabolism / Q000473:pathology; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009929:Organ Size / Q000187:drug effects; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013997:Time Factors
D002121:Calcium Channel Blockers; D011506:Proteins; D017311:Amlodipine; D012313:RNA; D004247:DNA